YK-11
$79.99
In stockYK-11 is an investigational synthetic steroidal compound studied for its activity at the androgen receptor. Often described as a selective androgen receptor modulator (SARM), it acts as a partial agonist, activating certain androgen-receptor responses in laboratory models. Its effects depend on the cellular setting and genes being examined.
| SKU | RC-RR-YK11-60Ct |
|---|---|
| Manufacturer | R+R Innovations |
| Form | Capsule |
| Strength | 4 mg |
| Size | 60 ct |
| Reported Result | Supplier spec pending verification |
| Stock | In stock |
| Documentation Status | Pending Final COA |
Product Description
YK-11 is an investigational synthetic steroidal compound studied for its activity at the androgen receptor. Often described as a selective androgen receptor modulator (SARM), it acts as a partial agonist, activating certain androgen-receptor responses in laboratory models. Its effects depend on the cellular setting and genes being examined.
Interest in YK-11 comes primarily from research involving muscle precursor cells and follistatin, a protein involved in regulating muscle-development signals. These findings have prompted discussion of its potential anabolic activity, but they do not establish muscle-building benefits in people.
What research has shown:
Androgen-receptor activity: Cell experiments found that YK-11 promoted movement of androgen receptors into the nucleus and influenced androgen-responsive gene expression. This demonstrates a biological mechanism rather than proven improvements in strength or body composition.
Increased follistatin expression: A study using mouse-derived C2C12 muscle precursor cells found that YK-11 increased follistatin expression. Blocking follistatin reduced the observed muscle-cell differentiation response, suggesting that follistatin contributed to the effect.
Changes in muscle-development markers: The same study reported increased expression of regulatory factors involved in muscle-cell differentiation, including MyoD, Myf5, and myogenin.
Myostatin-related claims: YK-11 is commonly marketed as a “myostatin inhibitor.” The proposed claim is that increasing follistatin could counteract myostatin signaling—a pathway that helps limit muscle growth—and thereby promote muscle development. This proposed mechanism draws on the laboratory finding of increased follistatin expression.
Storage and handling: Store capsules tightly sealed in a cool, dry location protected from heat, light, and moisture, unless the manufacturer specifies otherwise. Confirm identity, content, and stability using a lot-specific COA.
Third-party testing status.
| Batch / Lot | Reported Result | Tested | Partner | Status | Document |
|---|
.png)